RE:RE:Barron's Online: Valeant Pharma Is Too Risky to Touch CXR or CXRX is also dual listed they have shorts. There is less risk with Concordia also less short term and possibly long lerm return. CXR had their CC and spoke to their price drop so if VRX clears the air the same look for a similar short term recovery because VRX is an instituitional staple.
Point of my post is they have shorts just like VRX having shorts is good because as the proce rises they cover for profit or as they have too.
| Short Interest (Shares Short) | 1,717,000 | | Short Interest (Shares Short) - Prior | 1,362,000 | | Short % Increase / Decrease | 26 % | | Short Percent of Float | 6.18 % | | Short Interest Ratio (Days To Cover) | 2.8 | |
| Shares Float | 27,770,000 | | Trading Volume - Today | 1,237,792 | | Trading Volume - Average | 622,400 | | Trading Volume - Today vs. Average | 198.87 % | |